Cardiac Assist Devices – Market Insights – United States

The US cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, the availability and expanded use of devices for a wider range of patients, and favorable reimbursement conditions.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for cardiac assist devices in the US from 2019 through 2033.

Device recalls and product issues have impacted growth in the cardiac assist device market.

Which device segments have been hindered by recalls?

Which companies have lost market share due to recalls?

What are the primary reasons for which devices undergo recalls, and how does this differ by segment?

Innovative novel devices will play a major role in changing the landscape of the cardiac assist device market.

Which device segments are expected to see product innovations?

Which key design features are competitors emphasizing?

How will procedure volumes be affected by emerging products?

Clinical trials have a strong impact on the cardiac assist device market.

Which competitors have early feasibility studies underway?

Which additional indications are expected to receive approval based on positive trial results?

Which competitors are benefiting the most from accumulating clinical evidence?

The reimbursement environment for cardiac assist devices is evolving.

Which device segments have been impacted by recent CMS decisions?

How will changes to device reimbursement impact future growth in affected market segments?